Clinical Trial Update: Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating individualized pharmacokinetic profiling to automate insulin-only closed-loop glucose control in a bionic pancreas for type 1 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Type 1 Diabetes Mellitus | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-12-09